rs762961919
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP3BS2
The NM_025219.3(DNAJC5):c.491G>A(p.Arg164Lys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000089 in 1,461,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_025219.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- ceroid lipofuscinosis, neuronal, 4 (Kufs type)Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
- adult neuronal ceroid lipofuscinosisInheritance: AD Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAJC5 | ENST00000360864.9 | c.491G>A | p.Arg164Lys | missense_variant, splice_region_variant | Exon 4 of 5 | 1 | NM_025219.3 | ENSP00000354111.4 | ||
| DNAJC5 | ENST00000470551.1 | n.491G>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 4 of 6 | 2 | ENSP00000434744.1 | ||||
| DNAJC5 | ENST00000703637.1 | n.491G>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 4 of 6 | ENSP00000515413.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.0000280 AC: 7AN: 249906 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1461490Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727032 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
p.Arg164Lys (AGG>AAG): c.491 G>A in exon 4 of the DNAJC5 gene (NM_025219.2). The Arg164Lys missense change in the DNAJC5 gene has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is a conservative substitution of one positively charged amino acid for another at a position that is conserved in mammals but is not conserved in more distantly related species. In silico analysis is inconsistent with regard to the effect this variant may have on the protein structure/function. Therefore, based on the currently available information, it is unclear whether Arg164Lys is a disease-causing mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). -
Neuronal ceroid lipofuscinosis Uncertain:1
This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 164 of the DNAJC5 protein (p.Arg164Lys). This variant is present in population databases (rs762961919, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DNAJC5-related conditions. ClinVar contains an entry for this variant (Variation ID: 205376). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at